Management of intracranial aneurysms (IAs) is determined by patient age, risk of rupture,
and comorbid conditions. While endovascular and microsurgical interventions offer solutions …

The formation, growth, and rupture of intracranial aneurysms (IAs) involve hemodynamics,
blood pressure, external stimuli, and a series of hormonal changes. In addition, inflammatory …

Background and purpose Pathophysiological studies of saccular intracranial aneurysm (sIA)
disease have shown that inflammation plays a crucial role in sIA development …

Background and purpose Establishment of drug therapy to prevent rupture of unruptured
intracranial aneurysms (IAs) is needed. Previous human and animal studies have gradually …

Intracranial aneurysms (IAs), as a common cerebrovascular disease, claims a worldwide
morbidity rate of 3.2%. Inflammation, pivotal in the pathogenesis of IAs, influences their …

Aneurysmal subarachnoid hemorrhage is caused by intracranial aneurysm (IA) rupture and
results in high rates of mortality and morbidity. Factors contributing to IA generation, growth …

Intracranial aneurysms (IA) are a relatively frequent vascular abnormality. The prevailing
opinion is that cerebral aneurysmal disease is related to hemodynamic and genetic factors …

Subarachnoid hemorrhage resulting from intracranial aneurysms (IAs) is associated with
high rates of morbidity and mortality. Although trigger mechanisms in the pathogenesis of …

The treatment for intracranial aneurysm (IA) is socially important because of poor outcome
posed by subarachnoid hemorrhage after rupture. Further, the incidence of IAs in general …

Background: Saccular intracranial aneurysms (IAs) are outpouchings of the vessel wall of
intracranial arteries. Rupture of IAs results in subarachnoid hemorrhage which is associated …